EUCTR2004-000167-95-IT进行中（未招募）不适用
Duloxetine versus Placebo in the Prevention of Recurrence in Major Depressive Disorder
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- ELI LILLY
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive DisorderMedDRA version: 8.1Level: LLTClassification code 10025454Term: Major depressive disorder, recurrent episodeMajor Depressive DisorderEUCTR2004-000167-95-DEEli Lilly and Company Limited500
进行中（未招募）
不适用
Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive DisorderMajor Depressive DisorderEUCTR2004-000167-95-SEEli Lilly and Company Limited500
已完成
3 期
Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive DisorderDepressive Disorder, MajorNCT00105989Eli Lilly and Company514
已完成
3 期
Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive DisorderDepressive DisorderNCT00036309Eli Lilly and Company
进行中（未招募）
不适用
Duloxetine versus Placebo in the Treatment of Elderly Patients with Generalized Anxiety Disorder - HMGFGeneralized anxiety disorder (GAD)MedDRA version: 12.1Level: LLTClassification code 10018105Term: Generalized anxiety disorderEUCTR2009-010902-13-ATEli Lilly and Company288